WHO issues global guideline on the use of GLP-1 medicines in treating obesity
WHO
December 1, 2025
To address the growing global health challenge of obesity, which affects more than 1 billion people, WHO has released its first guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a chronic, relapsing disease.
Verticals
healthglobal
Originally published on WHO on 12/1/2025